Interestingly, the expression kinetic differed between the two compartments, as NKG2A was already upregulated by tumor-infiltrating antigen-specific CD8 T cells 24 h post VSV-GP-TAg boost, whereas in the blood overexpression was observed only one week later. The gene discussed is KLRC1; the disease is neoplasm.